Drugs for Lipomatosis, Multiple (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 89)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Acetylsalicylic acid |
Approved, Vet_approved |
Phase 4 |
|
50-78-2 |
2244 |
Synonyms:
2-(ACETYLOXY)BENZOATE
2-(ACETYLOXY)benzoIC ACID
2-Acetoxybenzenecarboxylate
2-ACETOXYBENZENECARBOXYLIC ACID
2-ACETOXYBENZOATE
2-ACETOXYBENZOIC ACID
2-CARBOXYPHENYL ACETATE
8-HOUR BAYER
A.S.A.
A.S.A. Empirin
ACARD
ACENTERINE
Acesal
Acetal
ACETARD
ACETICYL
Acetilsalicilico
Acetilum acidulatum
Acetisal
ACETOL
ACETONYL
ACETOPHEN
Acetophen®|acetylsalicylic acid|Aspirin®
ACETOSAL
ACETOSALIC ACID
ACETOSALIN
Acetoxybenzoic acid
ACETYLIN
Acetylsal
ACETYLSALIC ACID
ACETYLSALICYLATE
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
ACETYLSALICYLSÄURE
ACETYONYL
ACETYSAL
ACETYSALICYLIC ACID
Acid, acetylsalicylic
Acide 2-(acetyloxy)benzoique
ACIDE 2-(ACÉTYLOXY)BENZOÏQUE
Acide acetylsalicylique
ACIDE ACÉTYLSALICYLIQUE
Acido acetilsalicilico
ÁCIDO ACETILSALICÍLICO
Acido O-acetil-benzoico
ACIDUM ACETYLSALICYLICUM
Acimetten
Acisal
ACYLPYRIN
Adiro
ALKA RAPID
Aloxiprimum
ANADIN ALL NIGHT
ANGETTES 75
ASA
Asagran
ASATARD
Ascoden-30
Aspalon
Aspec
ASPERGUM
ASPIRDROPS
ASPIRIN
Aspirina
Aspirine
Aspro
ASPRO CLR
Asteric
Azetylsalizylsaeure
AZETYLSALIZYLSÄURE
BAY1019036
BAYER EXTRA STRENGTH
Bayer Extra Strength Aspirin For Migraine Pain
BENASPIR
Bialpirina
BIALPIRINIA
Bi-prin
BUFFERIN
CAPRIN
CARDIOASPIRINA
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
DANAMEP
Decaten
Delgesic
Dispril
DISPRIN CV
|
DISPRIN DIRECT
Dolean pH 8
Duramax
DURLAZA
EASPRIN
ECM
ECOLEN
ECOTRIN
EMPIRIN
ENDOSPRIN
ENDYDOL
ENPRIN
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EQUI-PRIN
Extren
GENCARDIA
Globentyl
Globoid
Helicon
Idragin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LEVIUS
Magnecyl
MAX STRGH ASPRO CLR
MEASURIN
Micristin
MICROPIRIN EC
Neuronika
Novid
NSC-27223
NSC-406186
Nu-seals
NU-SEALS 300
NU-SEALS 600
NU-SEALS 75
Nu-seals aspirin
NU-SEALS CARDIO 75
O-(ACETYLOXY)BENZOATE
O-(ACETYLOXY)BENZOIC ACID
O-accetylsalicylic acid
O-ACETOXYBENZOATE
O-ACETOXYBENZOIC ACID
O-Acetylsalicylate
O-ACETYLSALICYLIC ACID
O-CARBOXYPHENYL ACETATE
O-Carboxyphenyl acetic acid
PAYNOCIL
PERSISTIN
PHARMACIN
Pirseal
PLATET
PLATET 300
Polopirin
POLOPIRYNA
POSTMI 300
POSTMI 75
PREMASPIN
RHEUMINTABLETTEN
RHODINE
Rhonal
Salacetin
SALCETOGEN
SALETIN
Salicylate acetate
SALICYLIC ACID ACETATE
Salicylic acid acetic acid
Salicylic acid, acetate
SALOSPIR
Solfrin
SOLPRIN
SOLPRIN ACID
SOLPYRON
Solupsan
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
TASPRIN
TEMPERAL
TOLDEX
TRIAMINICIN
Triple-sal
Vanquish
VAZALORE
Xaxa
Yasta
Zorprin
|
|
2 |
|
Clopidogrel |
Approved |
Phase 4 |
|
120202-66-6, 113665-84-2 |
60606 |
Synonyms:
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
BMS Brand 1 OF clopidogrel bisulfate
BMS Brand 2 OF clopidogrel bisulfate
CLOPIDOGREL
Clopidogrel [Ban:Inn]
Clopidogrel besilate
Clopidogrel besylate
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel hydrochloride
CLOPIDOGREL HYDROGEN SULFATE
Clopidogrel mepha
Clopidogrel napadisilate
|
Clopidogrel sandoz
CLOPIDOGREL SULFATE
Clopidogrel, (+)(S)-isomer
Clopidogrel-mepha
Clopidogrelum
GREPID
Iscover
Isocover
Plavix
PLAVIX®
R 130964
R-130964
SR 25990
SR-25990
SR-25990C
|
|
3 |
|
Purinergic P2Y Receptor Antagonists |
|
Phase 4 |
|
|
|
4 |
|
Hormones |
|
Phase 4 |
|
|
|
5 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
6 |
|
Sitagliptin Phosphate |
|
Phase 4 |
|
654671-77-9 |
|
Synonyms:
JANUMET XR
JANUVIA
MK0431
MK-0431
ONO-5435
|
SITAGLIPTIN MONOPHOSPHATE ANHYDROUS
SITAGLIPTIN MONOPHOSPHATE MONOHYDRATE
SITAGLIPTIN PHOSPHATE
SITAGLIPTIN PHOSPHATE HYDRATE
SITAGLIPTIN PHOSPHATE MONOHYDRATE
|
|
7 |
|
HIV Protease Inhibitors |
|
Phase 4 |
|
|
|
8 |
|
Hypoglycemic Agents |
|
Phase 4 |
|
|
|
9 |
|
Dipeptidyl-Peptidase IV Inhibitors |
|
Phase 4 |
|
|
|
10 |
|
Incretins |
|
Phase 4 |
|
|
|
11 |
|
protease inhibitors |
|
Phase 4 |
|
|
|
Synonyms:
|
12 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
13 |
|
Platelet Aggregation Inhibitors |
|
Phase 4 |
|
|
|
14 |
|
Alprostadil |
Approved, Investigational |
Phase 2, Phase 3 |
|
745-65-3 |
5280723 |
Synonyms:
(-)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
(-)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
(-)-Prostaglandin e1
(+)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
(+)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
(11Α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-Oate
(11Α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-Oic acid
(13E)-(15S)-11,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11-alpha,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11-alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoic acid
11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid (acd/name 4.0)
11a,15a-Dihydroxy-9-oxo-13-trans-prostenoate
11a,15a-Dihydroxy-9-oxo-13-trans-prostenoic acid
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoate
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid
11Α,15α-dihydroxy-9-oxo-13-trans-prostenoate
11Α,15α-dihydroxy-9-oxo-13-trans-prostenoic acid
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
7-[(1R,2R,3R)-3-HYDROXY-2-[(1E,3S)-3-HYDROXYOCT-1-EN-1-YL]-5-OXOCYCLOPENTYL]HEPTANOIC ACID
Abbott brand OF alprostadil
Allphar brand OF alprostadil
Alprostadil
ALPROSTADIL ALFADEX
Alprostadil prostoglandin e1
Alprostadil®|MR-256|prostaglandin E<sub>1</sub>
Alprostadil(usan)
Alprostadilum
Astra brand OF alprostadil
AstraZeneca brand OF alprostadil
Befar
|
Caverject
Caverject impulse
Edex
Hoyer brand OF alprostadil
Janssen brand OF alprostadil
lipo PGE1
lipo-PGE1
L-Prostaglandin e1
Minprog
MR-256
Muse
NSC-165559
ONO-1608
Paladin brand OF alprostadil
PGE1
PGE-1
PGE₁
PGE1 Α-CD
PGE1alpha
Pharmacia brand 1 OF alprostadil
Pharmacia brand 2 OF alprostadil
Prink
PRINK (TN)
Prostaglandin e1
Prostaglandin e1alpha
Prostavasin
PROSTIN
Prostin VR
Prostin VR pediatric
Prostine VR
Schwarz brand OF alprostadil
Schwarz pharma brand OF alprostadil
Sugiran
U-10136
U-10136alprostadil
U-10136prostin
Vasaprostan
Viridal
VIRIDAL 10
VIRIDAL 20
VIRIDAL 5
VIRIDAL DUO
Vitaros
Vivus brand OF alprostadil
|
|
15 |
|
Hydrocortisone succinate |
Approved |
Phase 3 |
|
2203-97-6 |
3643 |
Synonyms:
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
Cortisol 21-(hydrogen succinate)
Cortisol succinate
HYDROCORTISONE HEMISUCCINATE
|
Hydrocortisone hemisuccinate anhydrous
Hydrocortisone hydrogen succinate
HYDROCORTISONE SUCCINATE
Hydroxycortisone succinate
NSC-7576
|
|
16 |
|
Hydrocortisone acetate |
Approved, Vet_approved |
Phase 3 |
|
50-03-3 |
|
Synonyms:
21-O-acetylcortisol
BARQUINOL HC
CHLOROMYCETIN HYDROCORT
COLIFOAM
CORTEF ACETATE
CORTIFOAM
Cortisol 21-acetate
CORTRIL
CORTUCID
DRICORT
EPIFOAM
FRAMYCORT
FUCIDIN H
GENTICIN HC
GENTISONE HC
|
GPPE EAR SUSP
GPPE EYE CRM
GPPE FOAM AERO
HC45 HYDROCORT
HEMSOL-HC
HEPACORT PLUS
HYDROCAL
HYDROCORTISONE 21-ACETATE
HYDROCORTISONE ACETATE
HYDROCORTONE
LANACORT
MICORT-HC
NEO-CORTEF
NSC-741
ORABASE HCA
|
|
17 |
|
Hydrocortisone |
Approved, Vet_approved |
Phase 3 |
|
50-23-7 |
3640 5754 |
Synonyms:
(11ALPHA,14BETA)-11,17,21-TRIHYDROXYPREGN-4-ENE-3,20-DIONE
(11b)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11Β)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(1S,2R,10S,11S,14S,15S,17S)-14,17-DIHYDROXY-14-(2-HYDROXYACETYL)-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
11 Epicortisol
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b,17a,21-Trihydroxy-4-pregnene-3,20-dione
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11-beta-Hydrocortisone
11beta-Hydroxycortisone
11-beta-Hydroxycortisone
11b-Hydrocortisone
11b-Hydroxycortisone
11-Epicortisol
11-Hydrocortisone
11Β,17α,21-trihydroxy-4-pregnene-3,20-dione
11Β-hydrocortisone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
17-Hydroxycorticosterone
4-Pregnen-11b,17a,21-triol-3,20-dione
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnen-11β,17α,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
ACETASOL HC
ACTICO МИХАИЛRT
Acticort
Acticort®|Efmody®|Plenadren®
Aeroseb HC
Aeroseb-HC
Alacort
Ala-cort
Ala-scalp
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort-HC
ANUGESIC HC
Anusol HC
ANUSOL PLUS HC
ANUSOL SOOTHING RELIEF
Anusol-HC
Aquacort
Aquanil HC
Balneol-HC
Barseb HC
Basan-corti
Beta-HC
b-HC
CaldeCORT spray
CALMURID HC
CANESTEN HC
Cetacort
Chronocort
CIPRO HC
Clear aid
Cleiton
Cobadex
Colocort
Compound F
CORLAN
Cor-oticin
Cortanal
Cor-tar-quin
Cort-dome
Cortef
CORTENEM
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisolonum
Cortisporin
Cortisporin otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cort-quin
CORTRIL
Cremesone
Cremicort-H
Cutisol
DAKTACORT
DAKTACORT HYDROCORT
Delacort
DERMA CARE HYDROCORT
Dermacort
Derm-aid
DERMASPRAY DEMANG
Dermil
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
ECONACORT
Ef corlin
Efcorbin
Efcortelan
EFCORTELAN P
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
EURAX-HC
EURAX-HYDROCORT
Evacort
EXE-CORT
Ficortril
Fiocortril
Flexicort
Foille insetti
Genacort
GERMOLOIDS HC
Glycort
GREGODERM
gyno-Cortisone
HC
|
HC #1
HC #4
HC (HYDROCORTISONE)
HC45
H-Cort
Heb cort
Heb-cort
Hi-cor
Hidalone
hidro-Colisona
Hidrocortisona
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
hydro-Adreson
hydro-Colisona
Hydrocort
HYDROCORT IN CALAMINE OILY
HYDROCORT IN CETOMACROGOL FOR A
HYDROCORT IN WTE SOFT PARAF
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone acetate
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone butyrate
Hydrocortisone free alcohol
Hydrocortisone in absorbase
Hydrocortisone sodium phosphate
Hydrocortisone valerate
Hydrocortisone, (11 alpha)-isomer
Hydrocortisone, (9 beta,10 alpha,11 alpha)-isomer
Hydrocortisonum
Hydrocortistab
Hydrocortisyl
HYDROCORTONE
HYDRODERM
HYDRODERM HC
hydro-RX
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone lotion
Idrocortisone
Incortin-H
Incortin-hydrogen
JUNGLE FOR
Kendall's compound F
Komed HC
Kyypakkaus
Lacticare HC
Lacticare-HC
Lactisona
Locoid
Lubricort
Maintasone
Medicort
Meusicort
Micort-HC
Mildison
MILDISON LIPOCREAM
Milliderm
neo-Cort-dome
neo-Cortef
Neosporin-H ear
Nogenic HC
NSC-10483
Nutracort
NYBADEX
Nystaform-HC
Ophthocort
Optef
Otalgine
Otic-neo-cort-dome
Otobiotic
Otocort
OTOSEPTIL
Otosone-F
OTOSPORIN
Pediotic suspension
Penecort
PERINAL
Permicort
Plenadren
Polcort H
Preparation H hydrocortisone cream
Prepcort
Prestwick_265
Prevex HC
Proctocort
PROCTOCREAM HC
Proctofoam
PROCTOFOAM HC
PROCTOSEDYL
Protocort
QUINOCORT
Racet
Rectoid
Reichstein's substance m
Remederm HC
Sanatison
Scalpicin capilar
Schericur
Scheroson F
SENTIAL HC
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral hydrocort
Tarcortin
Terra-cortril
TERRA-CORTRIL NYSTATIN
Texacort
Timocort
TIMODINE
Topicort
TOPISONE
Transderma H
Traumaide
TRI-CICATRIN
U-cort
Uniderm
UNIROID
UNIROID HC
Vioform-hydrocortisone
VoSol HC
Vytone
XYLOPROCT
Zenoxone
β-HC
|
|
18 |
|
Creatine |
Approved, Investigational, Nutraceutical |
Phase 3 |
|
57-00-1 |
586 |
Synonyms:
((Amino(imino)methyl)(methyl)amino)acetate
((Amino(imino)methyl)(methyl)amino)acetic acid
(alpha-Methylguanido)acetate
(alpha-Methylguanido)acetic acid
(a-Methylguanido)acetate
(a-Methylguanido)acetic acid
(N-Methylcarbamimidamido)acetate
(N-Methylcarbamimidamido)acetic acid
(Α-methylguanido)acetate
(Α-methylguanido)acetic acid
[[Amino(imino)methyl](methyl)amino]acetate
[[Amino(imino)methyl](methyl)amino]acetic acid
alpha-Methylguanidino acetate
alpha-Methylguanidino acetic acid
a-Methylguanidino acetate
a-Methylguanidino acetic acid
Cosmocair C 100
Creatin
Creatine
|
Creatine (8CI)
Creatine hydrate
Creatine, hydrate
Kreatin
Krebiozon
Methylglycocyamine
Methylguanidoacetate
Methylguanidoacetic acid
N-(Aminoiminomethyl)-N-methylglycine
N-(Aminoiminomethyl)-N-methyl-glycine
N-[(e)-AMINO(imino)methyl]-N-methylglycine
N-Amidinosarcosine
N-Carbamimidoyl-N-methylglycine
N-Methyl-N-guanylglycine
NSC-8752
Phosphagen
Pyrolysate
Α-methylguanidino acetate
Α-methylguanidino acetic acid
|
|
19 |
|
Bronchodilator Agents |
|
Phase 3 |
|
|
|
20 |
|
Adrenergic beta-Agonists |
|
Phase 3 |
|
|
|
21 |
|
Anti-Asthmatic Agents |
|
Phase 3 |
|
|
|
22 |
|
Adrenergic Agonists |
|
Phase 3 |
|
|
|
23 |
|
Adrenergic Agents |
|
Phase 3 |
|
|
|
24 |
|
Neurotransmitter Agents |
|
Phase 3 |
|
|
|
25 |
|
Respiratory System Agents |
|
Phase 3 |
|
|
|
26 |
|
Salmeterol Xinafoate |
|
Phase 3 |
|
94749-08-3 |
|
Synonyms:
GR-33343 G
GR-33343-G
GR-33343X
LIPO-202
|
SALMETEROL 1-HYDROXY-2-NAPHTHOATE
SALMETEROL XINAFOATE
SEREVENT
|
|
27 |
|
Liver Extracts |
|
Phase 2, Phase 3 |
|
|
|
28 |
|
bilirubin |
|
Phase 2, Phase 3 |
|
635-65-4 |
5280352 |
Synonyms:
(4Z,15Z)-Bilirubin ixa
(Z,Z)-Bilirubin ixa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinylbiline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinylbiline-8,12-dipropionic acid
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid
2,7,13,17-Tetramethyl-1,19-dioxo-3,18-divinyl-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoate
2,7,13,17-Tetramethyl-1,19-dioxo-3,18-divinyl-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
|
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
8,12-Bis(2-carboxyethyl)-2,7,13,17-tetramethyl-3,18-divinylbiladiene-ac-1,19(21H,24H)-dione
BILIRUBIN
Bilirubin IX alpha
Bilirubin ixalpha
Bilirubin IX-alpha
Bilirubin(Z,Z)
Bilirubin-ixalpha
Cholerythrin
Hematoidin
NSC-26685
|
|
29 |
|
Anti-Inflammatory Agents |
|
Phase 3 |
|
|
|
30 |
|
Hydrocortisone 17-butyrate 21-propionate |
|
Phase 3 |
|
|
|
31 |
|
Fluorouracil |
Approved |
Phase 2 |
|
51-21-8 |
3385 |
Synonyms:
5 Fluorouracil
5 Fluorouracil biosyn
5 FU
5 FU lederle
5 FU medac
5 HU hexal
5.F.U.
5-Fluoracil
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluracil
5FU
5-FU
5-FU lederle
5-FU medac
5-HU hexal
ACCUSITE
ACTIKERALL
Adrucil
Allergan brand OF fluorouracil
Arumel
Biosyn brand OF fluorouracil
Carac
Carzonal
CSP Brand OF fluorouracil
Dakota brand OF fluorouracil
Dakota, fluorouracile
Dermatech brand OF fluorouracil
Dermik brand OF fluorouracil
Effluderm
Efudex
Efudix
Efurix
Ferrer brand OF fluorouracil
Fluoro Uracil
Fluoro uracile icn
Fluoroblastin
Fluoroplex
Fluorouracil
Fluorouracil gry
Fluorouracil mononitrate
Fluorouracil monopotassium salt
Fluorouracil monosodium salt
Fluorouracil potassium salt
FLUORO-URACIL ROCHE
Fluorouracil teva brand
|
Fluorouracile dakota
Fluoro-uracile icn
Fluorouracil-gry
Fluorouracilo
Fluorouracilo ferrer far
Fluorouracilum
Fluoruracil
Fluouracil
Fluracedyl
FLURACIL
Fluracilum
Fluri
Fluril
Fluro Uracil
Flurodex
Flurouracil
Ftoruracil
FU
Gry brand OF fluorouracil
Haemato brand OF fluorouracil
Haemato fu
Haemato-fu
Hexal brand OF fluorouracil
ICN brand OF fluorouracil
Kecimeton
Medac brand OF fluorouracil
Neocorp brand OF fluorouracil
Neofluor
NSC-19893
Onkofluor
Onkoworks brand OF fluorouracil
Pharmachemie brand OF fluorouracil monosodium salt
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Ribosepharm brand OF fluorouracil
Riemser brand OF fluorouracil
RO-29757
RO-2-9757
Roche brand OF fluorouracil
Teva brand OF fluorouracil
Timazin
TOLAK
Ulup
URF
|
|
32 |
|
Cyclophosphamide |
Approved, Investigational |
Phase 2 |
|
50-18-0, 6055-19-2 |
2907 |
Synonyms:
(+-)-Cyclophosphamide
(+,-)-2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate
(RS)-Cyclophosphamide
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
Anhydrous cyclophosphamide
Anhydrous, cyclophosphamide
ASTA
Asta B 518
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
Ciclofosfamida
Ciclofosfamide
Clafen
Claphene
CP
CPA
CTX
CY
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide anhydrous
Cyclophosphamide monohydrate
Cyclophosphamide Sterile
Cyclophosphamide, (R)-isomer
Cyclophosphamide, (S)-isomer
Cyclophosphamidum
Cyclophosphan
Cyclophosphane
Cyclophosphoramide
|
Cyclostin
Cyklofosfamid
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan Lyoph
Endoxan
Endoxan R
Endoxana
Endoxanal
Endoxan-Asta
Endoxane
Enduxan
Genoxal
Hexadrin
LEDOXINA
Lyophilized Cytoxan
Mitoxan
Monohydrate, cyclophosphamide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
Neosar
Procytox
Rcra Waste Number U058
Revimmune
Semdoxan
Sendoxan
Senduxan
Zyklophosphamid
|
|
33 |
|
Deoxycholic acid |
Approved |
Phase 2 |
|
83-44-3 |
222528 |
Synonyms:
(3a,5a,12a)-3,12-DIHYDROXYCHOLAN-24-Oate
(3a,5a,12a)-3,12-DIHYDROXYCHOLAN-24-Oic acid
(3a,5b,12a)-3,12-Dihydroxycholan-24-Oate
(3a,5b,12a)-3,12-Dihydroxycholan-24-Oic acid
(3alpha,5alpha,12alpha)-3,12-DIHYDROXYCHOLAN-24-Oate
(3ALPHA,5ALPHA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID
(3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-Oate
(3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-Oic acid
(3Α,5α,12α)-3,12-dihydroxycholan-24-Oate
(3Α,5α,12α)-3,12-dihydroxycholan-24-Oic acid
(3Α,5β,12α)-3,12-dihydroxycholan-24-Oate
(3Α,5β,12α)-3,12-dihydroxycholan-24-Oic acid
12beta-Isomer deoxycholic acid
3a,12a-Dihydroxy-5b-cholanate
3a,12a-Dihydroxy-5b-cholanic acid
3alpha,12alpha-Dihydroxy-5beta-cholanate
3alpha,12alpha-Dihydroxy-5beta-cholanic acid
3beta-Isomer deoxycholic acid
3Α,12α-dihydroxy-5β-cholanate
3Α,12α-dihydroxy-5β-cholanic acid
5alpha-Isomer deoxycholic acid
5b-Cholanic acid-3a,12a-diol
5b-Deoxycholate
5b-Deoxycholic acid
7a-Deoxycholate
7a-Deoxycholic acid
7alpha-Deoxycholate
7alpha-Deoxycholic acid
7-Deoxycholate
7-Deoxycholic acid
7Α-deoxycholate
7Α-deoxycholic acid
Acid, 5alpha-isomer deoxycholic
Acid, choleic
Acid, deoxycholic
Acid, desoxycholic
Acid, dihydroxycholanoic
|
Acid, lagodeoxycholic
ATX-101
ATX-101|DCA|deoxycholate
Choleic acid
Cholerebic
Cholorebic
Degalol
Deoxycholatate
Deoxycholate
Deoxy-cholate
Deoxycholate, sodium
Deoxycholatic acid
Deoxycholic acid
Deoxy-cholic acid
Deoxycholic acid, 12beta isomer
Deoxycholic acid, 12beta-isomer
Deoxycholic acid, 3beta isomer
Deoxycholic acid, 3beta-isomer
Deoxycholic acid, 5alpha isomer
Deoxycholic acid, 5alpha-isomer
Deoxycholic acid, disodium salt
Deoxycholic acid, magnesium (2:1) salt
Deoxycholic acid, monoammonium salt
Deoxycholic acid, monopotassium salt
Deoxycholic acid, monosodium salt
Deoxycholic acid, sodium salt, 12beta-isomer
Desoxycholate
Desoxycholic acid
Desoxycholsaeure
Desoxycholsäure
Dihydroxycholanoic acid
DWJ211
DWJ-211
KYBELLA
Lagodeoxycholic acid
NSC-8797
Sodium deoxycholate
|
|
34 |
|
Isoprenaline |
Approved, Investigational |
Phase 1, Phase 2 |
|
7683-59-2 |
3779 |
Synonyms:
(+-)-Isoprenaline
(+-)-Isoproterenol
(±)-ISOPRENALINE
(±)-ISOPROTERENOL
1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol
1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol
3,4-Dihydroxy-a-[(isopropylamino)methyl]benzyl alcohol
3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol
3,4-Dihydroxy-α-[(isopropylamino)methyl]benzyl alcohol
4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol
a-(Isopropylaminomethyl)protocatechuyl alcohol
A-21
Aerolone
Aleudrin
Aleudrine
alpha-(Isopropylaminomethyl)protocatechuyl alcohol
Aludrin
Aludrine
Asiprenol
Asmalar
Assiprenol
Bellasthman
Bronkephrine
Epinephrine isopropyl homolog
Euspiran
Hydrochloride, isoproterenol
IPA
Isadrin
Isadrine
Isonorene
Isonorin
Isoprenalin
Isoprenalina
Isoprenaline
Isoprénaline
Isoprenalinum
Isopropydrin
Isopropyl noradrenaline
|
Isopropyladrenaline
Isopropylarterenol
Isopropylnoradrenaline
Isopropylnorepinephrine
Isoproterenol
Isoproterenol chloride
ISOPROTERENOL DL-FORM
Isoproterenol HCl
Isoproterenol hydrochloride
Isoproterenol sulfate
isoproterenol|Isuprel®|Medihaler-Iso®
Isorenin
Isuprel
Isuprel Mistometer
Isupren
Izadrin
L-Isopropylnoradrenaline
L-Isoproterenol
Medihaler-Iso
Neodrenal
Neo-Epinine
N-Isopropyl-b-dihydroxyphenyl-b-hydroxyethylamine
N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine
N-Isopropylnoradrenaline
N-Isopropylnorepinephrine
N-Isopropyl-β-dihydroxyphenyl-β-hydroxyethylamine
Noradrenaline, isopropyl
Norisodrine
Norisodrine Aerotrol
Novodrin
NSC-33791
NSC-9975
Proternol
Respifral
Saventrine
Sulfate, isoproterenol
Vapo-Iso
Α-(isopropylaminomethyl)protocatechuyl alcohol
|
|
35 |
|
Prednisolone phosphate |
Approved, Vet_approved |
Phase 1, Phase 2 |
|
302-25-0 |
|
Synonyms:
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-monophosphate
|
Prednisolone 21-phosphate
|
|
36 |
|
Prednisolone acetate |
Approved, Vet_approved |
Phase 1, Phase 2 |
|
52-21-1 |
|
Synonyms:
ECONOPRED
FLO-PRED
METICORTELONE
NSC-10966
OMNIPRED
PRED FORTE
|
PRED FTE
PRED MILD
PREDNISOLONE 21-ACETATE
PREDNISOLONE ACETATE
STERANE
ULTRACORTENOL
|
|
37 |
|
Prednisolone |
Approved, Vet_approved |
Phase 1, Phase 2 |
|
50-24-8 |
4894 5755 |
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11Β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
3,20-Dioxo-11b,17a,21-trihydroxy-1,4-pregnadiene
3,20-Dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene
3,20-Dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Codelcortone
Co-Hydeltra
Cordrol
CORTALONE
Cotogesic
Cotolone
Decaprednil
Decortin H
DEKOTIL
Delcortol
Delta F
Delta(1)-Dehydrocortisol
Delta(1)-Dehydrohydrocortisone
Delta(1)-Hydrocortisone
DELTA.1-CORTISOL
DELTA.1-Cortisol|Orapred®|Pediapred®
Delta-Cortef
Deltacortenol
DELTACORTRIL
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
Deltahydrocortisone
DELTALONE
Deltasolone
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
DESOWEN
Dexa-Cortidelt Hostacortin H
Di adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Dicortol
DILACORT
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
FERNISOLONE-P
Flamasone
Hostacortin H
HYDELTRA
Hydeltrasol
HYDELTRA-TBA
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
IMS904
Inflamase Forte
Inflamase Mild
I-Pred
Key-Pred
Klismacort
Lentosone
Lite Pred
Medrol
|
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
METICORTELONE
METI-DERM
Metreton
M-Predrol
NEO-DELTA-CORTEF
Nisolone
Nor-Pred T.B.A.
NSC-9120
NSC-9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
ORAPRED
Panafcortelone
Paracortol
Paracotol
PEDIAPRED
PEVANTI
POLY-PRED
PRDL
Precortalon
Precortancyl
Precortilon
PRECORTISYL
PRECORTISYL FTE
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
PREDL
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone acetate
Prednisolone sodium phosphate
Prednisolone tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
PRELONE
Prenolone
Rolisone
SCHERIPROCT
Scherisolon
SERVISONE
Solone
Steran
STERANE
Sterolone
Supercortisol
TRIDESILON
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
VERDESO
Δ(1)-dehydrocortisol
Δ(1)-dehydrohydrocortisone
Δ(1)-hydrocortisone
Δ-cortef
|
|
38 |
|
Methylprednisolone hemisuccinate |
Approved |
Phase 1, Phase 2 |
|
2921-57-5 |
1875 |
Synonyms:
Methylprednisolone hemisuccinate
Methylprednisolone hemisuccinic acid
|
Methylprednisolone hydrogen succinate
Methylprednisolone succinate
|
|
39 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 1, Phase 2 |
|
83-43-2 |
4159 6741 |
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6Α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
1-Dehydro-6alpha-methylhydrocortisone
1-Dehydro-6a-methylhydrocortisone
1-Dehydro-6α-methylhydrocortisone
6 Methylprednisolone
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6a-Methylprednisolone
6-Methylprednisolone
6Α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
6Α-methylprednisolone
Artisone-Wyeth
Besonia
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
Dopomedrol
Esametone
Firmacort
J3.872E
Lemod
Medesone
Medixon
Medlone 21
Medrate
Medric acid
Medrol
Medrol Adt Pak
Medrol Dosepak
Medrol®|U-67590A
Medrone
Mesopren
|
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
Nirypan
Noretona
NSC-19987
Predni N Tablinen
Promacortine
Reactenol
Sieropresol
Solomet
SOLU-MEDROL
Summicort
Suprametil
U-67590A
Urbason
Urbasone
Wyacort
Δ(1)-6a-methylhydrocortisone
Δ(1)-6α-methylhydrocortisone
|
|
40 |
|
Doxorubicin |
Approved, Investigational |
Phase 2 |
|
23214-92-8 |
31703 |
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
ADM
ADR
Adriablastin
Adriablastine
Adriamycin
Adriamycin PFS
Adriamycin RDF
Adriamycin Semiquinone
Adriamycin®|Caelyx® (liposomal doxorubicin)|Doxil®|doxorubicin hydrochloride
Adriblastin
Adriblastina
Adriblastine
Adrimedac
Baxter brand OF doxorubicin hydrochloride
Bedford brand OF doxorubicin hydrochloride
Bristol-myers squibb brand OF doxorubicin hydrochloride
Caelyx
Cell pharm brand OF doxorubicin hydrochloride
Columbia brand OF doxorubicin hydrochloride
DM2
DOXIL
Doxo
Doxo cell
Doxo-cell
Doxolem
DOXORUBICIN
Doxorubicin HCl
Doxorubicin hexal
Doxorubicin hydrochloride
|
Doxorubicin NC
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicina ferrer farm
Doxorubicina funk
Doxorubicina tedec
Doxorubicine
Doxorubicine [INN-French]
Doxorubicine baxter
Doxorubicinum
Doxorubicinum [INN-Latin]
Doxotec
Elan brand OF doxorubicin hydrochloride
Farmiblastina
Ferrer brand OF doxorubicin hydrochloride
Hexal brand OF doxorubicin hydrochloride
Hydrochloride, doxorubicin
HYDROXYDAUNORUBICIN
Kenfarma brand OF doxorubicin hydrochloride
Lemery brand OF doxorubicin hydrochloride
Medac brand OF doxorubicin hydrochloride
Myocet
Neocorp brand OF doxorubicin hydrochloride
NSC-123127
Onkodox
Onkoworks brand OF doxorubicin hydrochloride
Pfizer brand OF doxorubicin hydrochloride
Prasfarma brand OF doxorubicin hydrochloride
RDF Rubex
Resmycin
Ribodoxo
Ribosepharm brand OF doxorubicin hydrochloride
Rubex
Tedec meiji brand OF doxorubicin hydrochloride
Urokit doxo cell
Urokit doxo-cell
VALRUBICIN IMPURITY, DOXORUBICIN
|
|
41 |
|
Lapatinib |
Approved, Investigational |
Phase 1, Phase 2 |
|
231277-92-2, 388082-78-8 |
208908 |
Synonyms:
FMM
FMM|GW 572016|GW572016|Tykerb®|Tyverb®
GSK-572016
GW 572016
GW-2016
GW572016
GW-572016
GW572016F
GW-572016F
GW-572016X
LAP016
LAPATINIB
LAPATINIB DITOLUENESULFONATE MONOHYDRATE
|
Lapatinib ditosylate
LAPATINIB DITOSYLATE MONOHYDRATE
Lapatinib tosilate hydrate
N-(3-Chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine
N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine
N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulphonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine
N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine
N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine
N-{3-CHLORO-4-[(3-FLUOROPHENYL)METHOXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURANYL]-4-QUINAZOLINAMINE
Tycerb
Tykerb
TYVERB
|
|
42 |
|
D-Tyrosine |
Approved, Experimental, Investigational, Nutraceutical |
Phase 1, Phase 2 |
|
133585-56-5, 60-18-4, 556-02-5 |
1153 6057 |
Synonyms:
(-)-a-Amino-p-hydroxyhydrocinnamate
(-)-a-Amino-p-hydroxyhydrocinnamic acid
(-)-alpha-Amino-p-hydroxyhydrocinnamate
(-)-alpha-Amino-p-hydroxyhydrocinnamic acid
(-)-Α-amino-p-hydroxyhydrocinnamate
(−)-α-amino-p-hydroxyhydrocinnamic acid
(-)-Α-amino-p-hydroxyhydrocinnamic acid
(2S)-2-Amino-3-(4-hydroxyphenyl)propanoate
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
(2S)-2-AMINO-3-(4-HYDROXYPHENYL)PROPIONIC ACID
(2S)-2-AZANYL-3-(4-HYDROXYPHENYL)PROPANOIC ACID
(R)-2-Amino-3-(p-hydroxyphenyl)propionic acid
(R)-3-(p-Hydroxyphenyl)alanine
(S)-(-)-Tyrosine
(S)-2-Amino-3-(p-hydroxyphenyl)propionate
(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid
(S)-3-(p-Hydroxyphenyl)alanine
(S)-a-Amino-4-hydroxybenzenepropanoate
(S)-a-Amino-4-hydroxy-benzenepropanoate
(S)-a-Amino-4-hydroxybenzenepropanoic acid
(S)-a-Amino-4-hydroxy-benzenepropanoic acid
(S)-alpha-Amino-4-hydroxybenzenepropanoate
(S)-alpha-Amino-4-hydroxy-benzenepropanoate
(S)-alpha-amino-4-Hydroxybenzenepropanoic acid
(S)-alpha-Amino-4-hydroxy-benzenepropanoic acid
(S)-Tyrosine
(S)-Α-amino-4-hydroxybenzenepropanoate
(S)-α-amino-4-hydroxybenzenepropanoic acid
2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-propanoate
2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-propanoic acid
2-Amino-3-(4-hydroxyphenyl)propanoate
|
2-Amino-3-(4-hydroxyphenyl)propanoic acid
2-Amino-3-(p-hydroxyphenyl)propionate
2-Amino-3-(p-hydroxyphenyl)propionic acid
3-(4-Hydroxyphenyl)-L-alanine
3-(p-Hydroxyphenyl)alanine
4-hydroxy-L-phenylalanine
6-Hydroxysandoricin
Benzenepropanoate
Benzenepropanoic acid
D-Tyr
D-Tyrosin
FEMA NO. 3736
L Tyrosine
LEVODOPA IMPURITY, L-TYROSINE-
LEVODOPA RELATED COMPOUND L-TYROSINE
L-p-Tyrosine
L-Tyrosin
L-tyrosine
Methyl 2-[5,11-bis(acetyloxy)-13-(furan-3-yl)-16-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]-2-hydroxyacetic acid
NSC-82624
Para tyrosine
Para-tyrosine
p-Tyrosine
Tirosina
Tyr
Tyrosin
Tyrosine
Tyrosine, L isomer
Tyrosine, L-isomer
Tyrosinum
Y
|
|
43 |
|
Prednisolone hemisuccinate |
Experimental |
Phase 1, Phase 2 |
|
2920-86-7 |
4897 |
Synonyms:
(+)-prednisolone hemisuccinate
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-14-yl}-2-oxoethoxy)-4-oxobutanoate
Prednisolonbisuccinat
Prednisolone 21-hemisuccinate
Prednisolone 21-succinate
|
Prednisolone bisuccinate
PREDNISOLONE HEMISUCCINATE
Prednisolone hemisuccinic acid
Prednisolone hydrogen succinate
PREDNISOLONE SUCCINATE
|
|
44 |
|
Cortisone |
Experimental |
Phase 1, Phase 2 |
|
53-06-5 |
222786 |
Synonyms:
11-Dehydro-17-hydroxycorticosterone
17a,21-Dihydroxy-4-pregnene-3,11,20-trione
17alpha,21-Dihydroxy-4-pregnene-3,11,20-trione
17-Hydroxy-11-dehydrocorticosterone
17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate
17Α,21-dihydroxy-4-pregnene-3,11,20-trione
4-Pregnene-17a,21-diol-3,11,20-trione
4-Pregnene-17alpha,21-diol-3,11,20-trione
4-Pregnene-17α,21-diol-3,11,20-trione
Adreson
Andreson
Anusol HC
Balneol-HC
beta-HC
Colocort
Compound e
Corlin
Cortadren
Cortandren
Cortef
Cortef acetate
Cortisal
Cortisate
Cortison
Cortisona
CORTISONE
Cortisone acetate
Cortisonum
Cortistal
Cortivite
Cortogen
Cortone
Cortone acetate
Cortril
delta(4)-Pregnene-17a,21-diol-3,11,20-trione
|
Delta(4)-Pregnene-17alpha,21-diol-3,11,20-trione
Dermacort
Dricort
Flexicort
Florinef
Fludrocortisone acetate
Glycort
Hemsol-HC
Hi-cor
Incortin
Kendall'S compound
Kendall's compound e
Kortison
Locoid
Locoid lipocream
Micort-HC
Nogenic HC
NSC-9703
Orabase hca
Pandel
Pregn-4-en-17a,21-diol-3,11,20-trione
Pregn-4-en-17alpha,21-diol-3,11,20-trione
Pregn-4-en-17α,21-diol-3,11,20-trione
Prestwick_132
Reichstein fa
Reichstein's substance fa
Scheroson
Solu-cortef
Stie-cort
Texacort
Westcort
Wintersteiner's compound F
Δ(4)-pregnene-17a,21-diol-3,11,20-trione
Δ(4)-pregnene-17α,21-diol-3,11,20-trione
|
|
45 |
|
Gastrointestinal Agents |
|
Phase 2 |
|
|
|
46 |
|
Cardiotonic Agents |
|
Phase 1, Phase 2 |
|
|
|
47 |
|
Antineoplastic Agents, Hormonal |
|
Phase 1, Phase 2 |
|
|
|
48 |
|
Neuroprotective Agents |
|
Phase 1, Phase 2 |
|
|
|
49 |
|
Antiemetics |
|
Phase 1, Phase 2 |
|
|
|
50 |
|
Pharmaceutical Solutions |
|
Phase 1, Phase 2 |
|
|
|
Interventional clinical trials:
(show all 49)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Randomized, Open-label Single-center Trial of Lipo-prostaglandin E1 Improves Coronary Microcirculation Dysfunction in Patients With Ischemic Heart Disease Combine With Diabetes Mellitus |
Unknown status |
NCT03159559 |
Phase 4 |
Lipo-PGE1 |
2 |
The Effect of Sitagliptin on Brown Adipose Tissue and Whole-body Metabolism in Overweight Pre-diabetic Men |
Completed |
NCT02294084 |
Phase 4 |
Sitagliptin;placebo |
3 |
Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients |
Completed |
NCT02628106 |
Phase 4 |
Lipo-PGE1 |
4 |
Protective Effect of Lipo-PGE1 on Myocardial Injury Following Percutaneous Coronary Intervention |
Unknown status |
NCT01245855 |
Phase 3 |
lipo-PGE1 |
5 |
A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat in Non-Obese Subjects |
Completed |
NCT02397499 |
Phase 3 |
LIPO-202;Placebo |
6 |
A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat in Non-Obese Subjects |
Completed |
NCT02398188 |
Phase 3 |
LIPO-202;Placebo |
7 |
Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT |
Active, not recruiting |
NCT02338440 |
Phase 2, Phase 3 |
lipoprostaglandin E1 |
8 |
Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study |
Not yet recruiting |
NCT04821583 |
Phase 3 |
Hydrocortisone;Placebo |
9 |
A Double-Blind Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202 in Subjects Who Completed Either the LIPO-202-CL-18 or LIPO-202-CL-19 Study |
Terminated |
NCT02483533 |
Phase 3 |
LIPO-202;Placebo |
10 |
An Open-Label Study to Evaluate Retreatment With LIPO-202 |
Unknown status |
NCT02397525 |
Phase 2 |
LIPO-202 |
11 |
A Phase II Study of Pegylated Liposomal Doxorubicin (Lipo-Dox) Combined With Cyclophosphamide /5-Fluorouracil as Second Line Chemotherapy in the Treatment of Metastatic Breast Cancer |
Unknown status |
NCT01451580 |
Phase 2 |
Lipo-Dox |
12 |
A Double Blind Study to Evaluate the Safety and Efficacy of Collagenase Clostridium Histolyticum (AA4500) in the Treatment of Lipoma |
Completed |
NCT02249052 |
Phase 2 |
AA4500;placebo |
13 |
A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma |
Completed |
NCT01613313 |
Phase 2 |
Collagenase Clostridium Histolyticum |
14 |
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) Intralipomal Injections for the Treatment of Superficial Lipomas |
Completed |
NCT00608842 |
Phase 2 |
Deoxycholic Acid Injection;Placebo |
15 |
A Pilot Study: Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas |
Completed |
NCT00624416 |
Phase 1, Phase 2 |
Prednisolone synthetic cortisone and Isoproterenol together |
16 |
A Double Blind, Randomized, Multi-Center, Placebo-Controlled Phase 2B Clinical Trial for the Evaluation of Efficacy and Safety of RZL-012 in Subjects Having Dercum's Disease Lipomas |
Completed |
NCT04229030 |
Phase 2 |
RZL-012;Vehicle |
17 |
Phase I/II Open-label Randomized Multicenter Trial to Assess Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates (MVA HIV-B/ LIPO-5; LIPO-5/MVA HIV-B; GTU®-MultiHIV B / LIPO-5; GTU®-MultiHIV B/MVA HIV-B) in Healthy Volunteers at Low Risk of HIV Infection |
Completed |
NCT02038842 |
Phase 1, Phase 2 |
|
18 |
A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC Prime/LIPO-5 Boost in Healthy, HIV-1 Uninfected Adult Participants |
Completed |
NCT00076063 |
Phase 1, Phase 2 |
|
19 |
A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging in a Defined Special Population - Obese Subjects (BMI > or Equal to 30 kg/m2) |
Completed |
NCT02568319 |
Phase 2 |
LIPO-202;Placebo |
20 |
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat |
Completed |
NCT03005717 |
Phase 2 |
LIPO-202;Placebo for LIPO-202 |
21 |
Randomised Double Blinded Phase II AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptide (LIPO-5) Versus Placebo in Non Infected HIV Volunteers (ANRS VAC 18) |
Completed |
NCT00121758 |
Phase 2 |
|
22 |
A Dose-Ranging and Dose Frequency Study Evaluating the Safety and Efficacy of LIPO-102 for the Reduction of Abdominal Subcutaneous Adipose Tissue |
Completed |
NCT00918814 |
Phase 2 |
LIPO-102;Placebo |
23 |
A Single-masked, Placebo Controlled, Multi-center Pilot Study to Determine the Safety and Efficacy of Orbital Injections of a Fixed Dose of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease |
Completed |
NCT00954057 |
Phase 2 |
LIPO-102;Placebo |
24 |
A Double-Masked, Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity |
Completed |
NCT01096979 |
Phase 2 |
LIPO-102;Placebo |
25 |
Evaluation of a Therapeutic Immunization Strategy Associating a DNA Vaccine (GTU-MultiHIV B) Followed by a Lipopeptide Vaccine (LIPO-5) in the Control of Viral Replication Following Antiretroviral Treatment Interruption in HIV-1 Infected Patients With a CD4 Cell Count ≥ 600/mm3 |
Completed |
NCT01492985 |
Phase 2 |
|
26 |
A Dose Ranging Study of the Safety and Efficacy of LIPO-202 Healthy Patients With Subcutaneous Fat in the Periumbilical Area |
Completed |
NCT01802723 |
Phase 2 |
Drug: salmeterol xinafoate;Drug: Placebo |
27 |
A Multi-center, Randomized, Double-masked, Placebo-controlled, Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity |
Completed |
NCT01180465 |
Phase 2 |
LIPO-102;LIPO-102 Low;LIPO-102, Placebo |
28 |
An Open-Label, Randomized Phase 2a Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas |
Recruiting |
NCT05387733 |
Phase 2 |
10 mg CBL-514 per injection;15 mg CBL-514 per injection |
29 |
A Phase II Study of Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer |
Terminated |
NCT00465673 |
Phase 2 |
Liposomal Doxorubicin |
30 |
Randomized Study on HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides (LIPO-6T) in Patients Treated Early With HAART During Primary Infection. ANRS 095 PRIMOVAC |
Terminated |
NCT00196651 |
Phase 2 |
IL-2 |
31 |
A Phase I/II Study of Lapatinib (Tykerb) Plus Liposomal Doxorubicin Hydrochloride ( Lipo-Dox) for Patients With ErbB2 Positive Metastatic Breast Cancer |
Terminated |
NCT01658358 |
Phase 1, Phase 2 |
Lapatinib;Lipo-Dox |
32 |
Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Sequential Dose-Escalation Study of the Pharmacokinetics, Safety, and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) Intralipomal Injections for the Treatment of Superficial Lipomas |
Completed |
NCT00422188 |
Phase 1 |
Deoxycholic Acid Injection;Placebo |
33 |
An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers |
Completed |
NCT00918606 |
Phase 1 |
LIPO-102 |
34 |
Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL) |
Not yet recruiting |
NCT05351164 |
Phase 1 |
Metreleptin |
35 |
Developing a Biomarker for Monitoring Clinical Outcomes in Children With Spinal Lipoma |
Unknown status |
NCT02722681 |
|
|
36 |
Insight Into Subcutaneous Adipose Tissue Disorders As Part of The TREAT Program (Treatment, Research, Education, Adipose Tissue) at the University of Arizona |
Unknown status |
NCT02838277 |
|
|
37 |
Identification of Mutations Responsible for Rare Familial Skin Diseases by Next Generation Sequencing |
Unknown status |
NCT02509650 |
|
|
38 |
Ultrasound-Guided Regional Blockade for Lipoma Excision: a New Approach to an Old Technique |
Completed |
NCT02753361 |
|
|
39 |
Inzisionelle Negative Drucktherapie Nach Resektion Von Weichteiltumoren - Eine Prospektive, Randomisierte, Kontrollierte Klinische Studie |
Completed |
NCT03900078 |
|
|
40 |
An Investigator-initiated Study Assessing the Effect of Intermittent Pneumatic Compression (IPC) on Symptoms and Quality of Life in Women With Lipo-lymphedema (Lipedema With Swelling) |
Completed |
NCT04213989 |
|
|
41 |
Ultrasound Characterization of Lipo-hypertrophy in Type 1 Diabetes Mellitus |
Completed |
NCT02278926 |
|
|
42 |
Randomized Multicenter Crossover Study to Compare the Plasmat® Futura Heparin Induced Extracorporeal Lower Density Lipo-Protein (LDL) Precipitation (H.E.L.P.) Apheresis System to the Approved Secura System in the Reduction of LDL-c in Patients With Hypercholesterolemia |
Completed |
NCT00526058 |
|
|
43 |
Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class (i.v. Lipo and Glyco-peptides) in Patients With ABSSSI |
Completed |
NCT04298463 |
|
Xydalba;vancomycin, teicoplanin or daptomycin |
44 |
Effect of 60-days Saccharomyces Boulardii and Superoxide Dismutase Supplementation on Body Composition, Hunger Sensation, Pro/Antioxidant Ratio, Inflammation and Hormonal Lipo-metabolic Biomarkers in Obese Adults: a Double-blind, Placebo-controlled Trial |
Completed |
NCT04919850 |
|
|
45 |
A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever |
Completed |
NCT03511820 |
|
Lipo-AB® (amphotericin B) liposome |
46 |
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas |
Recruiting |
NCT04224064 |
|
|
47 |
Evaluation of the Efficacy of "Aquoral Lipo" Artificial Tears in Contact Lens Wearers With Discomfort Symptoms |
Recruiting |
NCT05290727 |
|
|
48 |
Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation : Feasibility, Complications, Evaluation of Aesthetic Result and Quality of Life. |
Active, not recruiting |
NCT04343820 |
|
|
49 |
Oral and Buccal Evaluation of Mobile Beach Workers |
Suspended |
NCT04236700 |
|
|
|